ReactWell Licenses ORNL Catalyst for Energy Conversion Applications

ReactWell, a NOBIC client and tenant, recently announced a partnership with Oak Ridge National Lab. The Company has licensed a novel waste-to-fuel technology to improve energy conversion methods for cleaner, more efficient oil and gas, chemical, and bioenergy production. ReactWell will combine this process with existing technologies to make a more efficient and effective solutions for its customers.

CADEX Genomics Launches Clinical Study

Cadex Genomics, a newly funded company based on technology developed in Louisiana, recently announced the launch of a clinical study at Rocky Mountain Cancer Center. The company had recently raised $1.5 Million to cover operations and clinical studies to bring its initial product, Alibrex, to market. Veteran entrepreneur and Alibrex inventor Sudhir Sinha has joined the company as the Chief Scientific Officer. Alibrex is a blood-based assay that indicates when a patient with a stage IV solid tumor cancer is not responding to therapy within two weeks after treatment commences. Learn more about Cadex and its products at